Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: A meta-analysis of randomized clinical trials*
|
|
- Brenda Clarke
- 6 years ago
- Views:
Transcription
1 Review Articles Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: A meta-analysis of randomized clinical trials* Hooman Kamel, MD; Babak B. Navi, MD; Kazuma Nakagawa, MD; J. Claude Hemphill III, MD, MAS; Nerissa U. Ko, MD Objectives: Randomized trials have suggested that hypertonic saline solutions may be superior to mannitol for the treatment of elevated intracranial pressure, but their impact on clinical practice has been limited, partly by their small size. We therefore combined their findings in a meta-analysis. Data Sources: We searched for relevant studies in MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, and ISI Web of Knowledge. Study Selection: Randomized trials were included if they directly compared equiosmolar doses of hypertonic sodium solutions to mannitol for the treatment of elevated intracranial pressure in human subjects undergoing quantitative intracranial pressure measurement. Data Extraction: Two investigators independently reviewed potentially eligible trials and extracted data using a preformed data collection sheet. Disagreements were resolved by consensus or by a third investigator if needed. We collected data on patient demographics, type of intracranial pathology, baseline intracranial pressure, osms per treatment dose, quantitative change in intracranial pressure, and prespecified adverse events. Our primary outcome was the proportion of successfully treated episodes of elevated intracranial pressure. Data Synthesis: Five trials comprising 112 patients with 184 episodes of elevated intracranial pressure met our inclusion criteria. In random-effects models, the relative risk of intracranial pressure control was 1.16 (95% confidence interval, ), and the difference in mean intracranial pressure reduction was 2.0 mm Hg (95% confidence interval, 1.6 to 5.7), with both favoring hypertonic saline over mannitol. A mild degree of heterogeneity was present among the included trials. There were no significant adverse events reported. Conclusions: We found that hypertonic saline is more effective than mannitol for the treatment of elevated intracranial pressure. Our meta-analysis is limited by the small number and size of eligible trials, but our findings suggest that hypertonic saline may be superior to the current standard of care and argue for a large, multicenter, randomized trial to definitively establish the first-line medical therapy for intracranial hypertension. (Crit Care Med 2011; 39: ) KEY WORDS: intracranial hypertension; intracranial pressure; mannitol; hypertonic saline; meta-analysis; randomized controlled trial *See also p From the Department of Neurology, University of California, San Francisco, CA. Supported, in part, by the Department of Neurology, University of California, San Francisco, CA. The authors have not disclosed any potential conflicts of interest. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal s web site ( For information regarding this article, hooman.kamel@ucsf.edu Copyright 2011 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins DOI: /CCM.0b013e318206b9be Mannitol is recommended as the first-line osmotic agent for the treatment of intracranial hypertension attributable to traumatic brain injury (TBI) (1), intracerebral hemorrhage (2), malignant cerebral infarction (3), subarachnoid hemorrhage (4), and acute liver failure (5). Numerous studies have shown that mannitol is effective in decreasing intracranial pressure (ICP) (6), and at least one randomized clinical trial has shown that mannitol reduces mortality compared to barbiturates in patients with elevated ICP from TBI (7). However, mannitol has many clinically important adverse effects, such as renal failure and hypovolemia (6, 8). These adverse effects of mannitol have led to increasing enthusiasm about the use of hypertonic saline formulations, which can reduce ICP without causing volume contraction and with less risk of nephrotoxicity (9 12). Several randomized clinical trials have suggested that sodium-based hypertonic solutions may be superior to mannitol in reducing ICP (13 17), but the impact of these studies on clinical practice has been limited, partly because of the different specific formulations used and partly because of the small size of these studies (18). Therefore, to better understand the relative efficacy of these two forms of osmotic therapy, we performed a meta-analysis of randomized clinical trials comparing hypertonic sodium solutions and mannitol for the treatment of elevated ICP. This report of our study conforms to the recommendations of the QUORUM statement on the quality of reporting for meta-analyses of randomized clinical trials (19). MATERIALS AND METHODS Inclusion Criteria. We included randomized clinical trials involving human subjects (without exclusions based on age, sex, or race) undergoing some method of quantitative ICP measurement (e.g., intraparenchymal monitor, external ventricular drain, lumbar drain, and others) and displaying evidence of ele- 554 Crit Care Med 2011 Vol. 39, No. 3
2 vated ICP, without regard for the underlying cause. Eligible trials directly compared the effect on ICP of equiosmolar doses (within 20%) of hypertonic sodium and mannitol solutions. We included trials using any formulation containing at least 3% sodium chloride or equivalent (e.g., hypertonic sodium plus lactate, starch, etc.). We included trials involving an unblinded or crossover design, as long as the treatment allocation was randomized. We excluded trials using varying doses or varying infusion times (e.g., titrating drug to effect), because this would have precluded standardized comparison of the two drugs. Data Sources. We performed an electronic search of MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, and ISI Web of Knowledge for relevant studies published in any language between January 1967 and April We complemented this by using the Related Articles function on PubMed and searching the reference lists of relevant articles. To assess for possible publication bias, we searched for unpublished abstracts in Scopus and unreported studies in the registry, but we did not plan to include such studies in our analysis because of concerns about methodological limitations of unpublished trials (20). Search Strategy. We used text words and medical subject heading terms to identify studies involving the study population and intervention of interest (i.e., a comparison of mannitol and hypertonic saline in patients with elevated ICP; for full details of the search strategy, see Supplementary Data File 1 [Supplemental Digital Content 1, To ensure the inclusion of studies not specifically indexed to terms related to ICP, we included search terms for common causes of elevated ICP, including TBI, hemorrhage, and stroke. To limit our search to randomized clinical trials, we used the Cochrane highly sensitive search strategy for MEDLINE and a similar strategy for EMBASE (21). One investigator (H.K.) reviewed the titles and abstracts of all studies identified in this way and excluded those that were obviously irrelevant. The full articles of the remaining studies were retrieved and independently reviewed by two investigators (H.K. and B.N.) using a structured form to determine eligibility and extract data. Disagreements were resolved by consensus or by a third investigator (K.N.) if needed. We contacted study authors for clarifications and further information as necessary. Quality Assessment. We formally evaluated the quality of eligible studies using the Cochrane Collaboration s tool for assessing the risk of bias in randomized trials (22). Specifically, studies were judged on the adequacy of the random sequence generation, allocation concealment, and blinding; the completeness of outcome data; the possibility of selective outcome reporting; and the existence of other potential sources of bias. Data Extraction. For each trial, we recorded the number, age, and sex of patients; number of episodes of elevated ICP treated with a randomized allocation of a study drug; total osms per treatment dose; mean baseline ICP in each group; and the lowest mean ICP or the maximum mean change in ICP in each group within 60 mins of treatment. Our primary outcome was the proportion of cases in which randomized drug administration resulted in control of ICP, as defined in each study. We recorded the reported frequency of the following prespecified adverse events, as defined in each study: acute renal failure, pulmonary edema, hypotension, coagulopathy, and compartment syndrome from extravasation. We expected to include trials with crossover designs and multiple treatments per patient, so all data were extracted from intention-to-treat analyses only, with the unit of analysis being each randomized dose of study drug administered to treat a new episode of elevated ICP. In other words, crossover treatments for episodes of elevated ICP not responsive to the initial therapy were not included, but crossover treatments for new recurrent episodes of elevated ICP in the same patient were allowed as long as randomization was maintained. Statistical Analysis. In our primary analysis, we calculated the pooled relative risk of ICP control with hypertonic saline compared to mannitol. We expected heterogeneity among the trials from differences in hypertonic sodium formulations and subject populations; therefore, we used a random-effects model based on the method of DerSimonian and Laird. Because we expected a small number of eligible studies, and because randomeffects models may not perform as well with few studies, we also performed an analysis using a fixed-effects model for comparison. In our secondary analysis, we used the same strategy to calculate the weighted difference between the two treatment groups in mean ICP reduction. If the mean change in ICP was not reported, we calculated it by subtracting the mean posttreatment ICP from the mean pretreatment ICP, and we then calculated the SD of the mean difference using the reported p value. If the change in ICP was not reported in terms of mean and SD, we used the median to represent the mean, because this has been shown to be reasonably accurate when the sample size is approximately 25 (23), and then calculated the SD from the p value of the difference in means within the study (24). To examine the effects of this statistical assumption regarding the mean and median, we performed sensitivity analyses by excluding such studies altogether or alternatively imputing the SD based on those of the other studies (25). We assessed for heterogeneity among studies using Cochran s Q statistic and Higgins I 2 statistic; significant heterogeneity was prespecified as p.10 or I 2 50% (26). Because these statistical methods may be underpowered to detect heterogeneity, we explored possible sources of heterogeneity with prespecified subgroup and meta-regression analyses based on the following categories: type of hypertonic sodium formulation (containing starch/dextran or not), osms per dose ( or 300 mosm, corresponding to a standard 50-g dose of mannitol), baseline mean ICP ( or 25 mm Hg, because some studies used this as the treatment threshold instead of 20 mm Hg), type of intracranial pathology (TBI, subarachnoid hemorrhage, intracerebral hemorrhage, and stroke), and age (adult vs pediatric subjects). RESULTS Five studies enrolling a total of 112 adult patients met our eligibility criteria (13, 14, 17, 18, 27) (see Supplemental Fig. 1, which describes the flow diagram of search results and study selection [Supplemental Digital Content 2, We did not find any potentially eligible unpublished abstracts or unreported trials, and a funnel plot did not reveal visual evidence of publication bias. All studies were limited by the absence of blinding, but otherwise the overall methodological quality of the included studies was fairly high, especially because the main outcomes were quantified objective ICP readings. All the trials were small (the largest enrolled 40 patients), but several amplified their sample size by including multiple episodes of elevated ICP per patient (13, 14, 17). Afifi et al (27) and Francony et al (18) compared mannitol to hypertonic sodium chloride, Battison et al (14) and Schwarz et al (13) used hypertonic sodium chloride plus starch, and Ichai et al (17) used hypertonic sodium lactate. Most studies included a mix of patients with TBI, stroke, intracerebral hemorrhage, and subarachnoid hemorrhage (13, 14, 18); one study exclusively consisted of patients with TBI (17) and one exclusively consisted of patients with recently resected supratentorial tumors (27) (Table 1). The average age of patients was 38 yrs ( 13 yrs), and 64% were men. None of the studies reported the occurrence of any of our prespecified adverse events. Among the 112 patients in the eligible trials, a total of 184 episodes of intracranial hypertension were randomly treated with mannitol or a hypertonic sodium solution. Mannitol was effective in controlling elevated ICP in 69 of 89 episodes (78%; 95% confidence interval [CI], 67% 86%), whereas hypertonic sodium solutions were effective in 88 of 95 episodes (93%; 95% CI, 85% 97%). The pooled relative risk of ICP control using Crit Care Med 2011 Vol. 39, No
3 Table 1. Study characteristics Study Characteristics Afifi et al (27) Study Battison et al (14) Francony et al (18) Ichai et al (17) Schwarz et al (13) Study year Country Egypt UK France France Germany Subjects (n) Age (yr) 36 (6) Not available 40 (14) 36 (15) 57 (11) Cases Tumor (n 40) TBI (n 6) TBI (n 17) TBI (n 34) Stroke (n 8) Subarachnoid hemorrhage (n 3) Intracranial hemorrhage (n 2) Intracranial hemorrhage (n 1) Stroke (n 1) Mannitol formulation 20% 20% 20% 20% 20% Sodium formulation 3.0% sodium chloride 7.5% sodium chloride 6% 7.45% sodium chloride Sodium lactate 7.5% sodium chloride hydroxyethyl starch (60 g/l) dextran-70 Mannitol dose 5.49 mosm/kg 249 mosm 255 mosm 1.74 mosm/kg 220 mosm Sodium dose 5.49 mosm/kg 250 mosm 255 mosm 1.65 mosm/kg 257 mosm Baseline ICP (mm Hg) Mannitol 31 (4) 24.0 (18.8, 25.9) a 31 (6) N/A 26.1 (1.5) Sodium 31 (4) 22.0 ( ) a 27 (3) N/A 28.6 (4.8) Definition of ICP 20 mm Hg 18 mm Hg 20% below Decrease 5 mmhg 10% below baseline control baseline or absolute 20 mm Hg ICP control Mannitol 16 of 20 (80%) 14 of 18 (78%) 10 of 10 (100%) 19 of 27 (70%) 10 of 14 (71%) Sodium 19 of 20 (95%) 16 of 18 (89%) 9 of 10 (90%) 28 of 31 (90%) 16 of 16 (100%) ICP decrease Mannitol 13 (5) 7.5 ( ) a 14 (8) 5 (2) 4.6 (4.7) Sodium 12 (5) 13.0 ( ) a 10 (5) 8 (2) 11.0 (7.1) ICP, intracranial pressure; TBI, traumatic brain injury. Continuous measures are expressed as mean (SD), except ICP measurements from Battison et al, a which are expressed as median (interquartile range). ICP control denotes the proportion of episodes of elevated ICP successfully treated with a randomized dose of study medication. ICP decrease denotes the maximum decrease in mean ICP (mm Hg) within 60 mins of study drug administration. (p.26, I 2 24% in our primary analysis). We did not find any eligible pediatric trials, and we did not have sufficient data to perform subgroup analysis based on the type of intracranial pathology. In our other prespecified subgroup analyses, there were no clear differences in effect size among subgroups based on the type of hypertonic saline formulation, dose per treatment, or baseline mean ICP. There were too few eligible studies to perform meta-regression. DISCUSSION Figure 1. Forest plot showing relative risk (RR) of successful control of elevated intracranial pressure. CI, confidence interval. hypertonic saline compared to mannitol was 1.16 (95% CI, , p.046; Fig. 1). The weighted mean difference in ICP reduction using hypertonic saline compared to mannitol was 2.0 mm Hg (95% CI, 1.6 to 5.7 mm Hg, p.276; Fig. 2). In comparison, when a fixedeffects model was applied, our point estimates did not substantially change but the confidence intervals narrowed; the relative risk of ICP control favoring hypertonic saline was 1.20 (95% CI, , p.007), and the weighted mean difference in ICP reduction using hypertonic saline compared to mannitol was 2.0 mm (95% CI, mm Hg, p.036). Our prespecified tests indicated a mild degree of heterogeneity among trials In this meta-analysis of five randomized clinical trials, we found that hypertonic sodium solutions are more effective than mannitol in controlling episodes of elevated ICP. We also found a trend toward greater quantitative ICP reduction in the hypertonic sodium group. Individually, two of the five trials reported statistically greater quantitative ICP reduction using hypertonic sodium compared to mannitol, one showed a trend favoring hypertonic sodium, one showed equivalence, and one showed a statistically sig- 556 Crit Care Med 2011 Vol. 39, No. 3
4 ptosis (42). Overall, the conflicting nature of these basic science considerations suggests that the preferred agent for the treatment of intracranial hypertension ultimately must be established through large, well-performed, randomized human trials. CONCLUSIONS Figure 2. Forest plot showing difference in mean quantitative reduction of intracranial pressure (mm Hg). WMD, weighted mean difference; CI, confidence interval. nificant advantage to mannitol. None individually were sufficiently powered to show a difference in the proportion of episodes of elevated ICP that were successfully treated, but the pooled results indicate that hypertonic sodium solutions are, on average, more effective. In selecting our primary outcome, we chose each study s clinical definition of ICP control, because this is a more clinically relevant end point than the mean quantitative decrease in ICP, which can mask significant intragroup heterogeneity of treatment effect. Regardless, in our secondary analysis, there was a strong trend toward greater quantitative ICP reduction in patients treated with hypertonic saline compared to mannitol; this became statistically significant when a fixed-effects model was used. The lack of a uniform treatment effect among all the trials is not surprising; we expected heterogeneity from methodological differences among the trials, specifically in terms of study population, treatment thresholds, and types of hypertonic sodium formulation. Our meta-analysis revealed only a mild degree of heterogeneity, and our prespecified subgroup analyses did not reveal an explanation for differences in effect size. Only one of the five trials (by Francony et al [18]) failed to show a trend favoring hypertonic sodium formulations, and we noted no obvious methodological differences between this trial and the others that would explain this disparity. However, this study was the smallest of the five included trials, and its discordant results may be attributable to the effect of chance. This explanation is supported by the results of seven observational studies Crit Care Med 2011 Vol. 39, No. 3 demonstrating the effectiveness of hypertonic saline in lowering ICP after failure of standard mannitol therapy (28 34). Another observational study found no significant difference between the efficacy of mannitol and hypertonic saline, but the latter had a longerlasting effect (35). Furthermore, two randomized trials that did not meet our inclusion criteria support the superiority of hypertonic saline therapy. A trial by Vialet et al (15) was not eligible because different osms per dose were used in the two treatment groups (361 osms for hypertonic saline vs. 175 osms for mannitol); nevertheless, they found that 7.5% sodium chloride was more effective in treating refractory intracranial hypertension. A trial by Harutjunyan et al (16) did not qualify because study drugs were titrated to effect, making a standardized comparison difficult; nevertheless, they found that 7.2% sodium chloride plus hydroxyethyl starch was superior to mannitol in reducing ICP. In addition to the clinical evidence reviewed, there are also numerous biochemical and physiologic considerations when choosing between hypertonic saline and mannitol for the treatment of elevated ICP. For example, hypertonic saline solutions result in significant volume expansion, improved cardiac output, improved regional blood flow, improved cerebrospinal fluid absorption (36), and beneficial immunomodulation (11). In addition, hypertonic saline may be superior to mannitol in regard to brain oxygenation and cerebral hemodynamics (33). However, mannitol may improve microvascular cerebral blood flow (37), reduce blood viscosity (38), improve blood rheology (6, 39), reduce cerebrospinal fluid production (40), promote freeradical scavenging (41), and inhibit apo- The need for more rigorous clinical data prompted us to perform this metaanalysis of existing randomized trials. Our study is limited by the small number and size of eligible trials, as well as their methodological differences, lack of rigorous adverse event reporting, and failure to control for clustering among patients receiving multiple doses of study drug. These limitations preclude a firm recommendation to preferentially use hypertonic saline as first-line therapy, but our findings indicate that hypertonic sodium solutions are, on average, superior to mannitol for the treatment of elevated ICP and argue for a large multicenter study comparing these two therapies. Our results suggest an absolute effect size of approximately 15% in favor of hypertonic saline, and a trial would require approximately 100 patients in each arm to have 80% power to detect this difference in the rate of ICP control between the two groups. Ideally, such a trial would incorporate a uniform hypertonic sodium solution and, more importantly, also include assessment of long-term neurologic outcomes. While we await such a trial, the balance of evidence indicates that hypertonic saline is more effective than mannitol for the treatment of intracranial hypertension. REFERENCES 1. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al: Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma 2007; 24:S14 S20 2. Broderick J, Connolly S, Feldmann E, et al: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007; 116: e391 e Adams HP Jr, del Zoppo G, Alberts MJ, et al: Guidelines for the early management of 557
5 adults with ischemic stroke: A guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: Bederson JB, Connolly ES Jr, Batjer HH, et al: Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40: Stravitz RT, Kramer AH, Davern T, et al: Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007; 35: Diringer MN, Zazulia AR: Osmotic therapy: Fact and fiction. Neurocrit Care 2004; 1: Schwartz ML, Tator CH, Rowed DW, et al: The University of Toronto head injury treatment study: A prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 1984; 11: Oken DE: Renal and extrarenal considerations in high-dose mannitol therapy. Ren Fail 1994; 16: Bentsen G, Breivik H, Lundar T, et al: Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: A prospective clinical trial in critically ill patients with subarachnoid haemorrhage. Acta Anaesthesiol Scand 2004; 48: Bentsen G, Breivik H, Lundar T, et al: Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med 2006; 34: White H, Cook D, Venkatesh B: The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg 2006; 102: Forsyth LL, Liu-DeRyke X, Parker D Jr, et al: Role of hypertonic saline for the management of intracranial hypertension after stroke and traumatic brain injury. Pharmacotherapy 2008; 28: Schwarz S, Schwab S, Bertram M, et al: Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998; 29: Battison C, Andrews PJ, Graham C, et al: Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005; 33: ; discussion Vialet R, Albanèse J, Thomachot L, et al: Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 ml/kg 7.5% saline is more effective than 2 ml/kg 20% mannitol. Crit Care Med 2003; 31: Harutjunyan L, Holz C, Rieger A, et al: Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients A randomized clinical trial [ISRCTN ]. Crit Care 2005; 9:R530 R Ichai C, Armando G, Orban JC, et al: Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med 2009; 35: Francony G, Fauvage B, Falcon D, et al: Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008; 36: Moher D, Cook DJ, Eastwood S, et al: Improving the quality of reports of metaanalyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: Cook DJ, Guyatt GH, Ryan G, et al: Should unpublished data be included in metaanalyses? Current convictions and controversies. JAMA 1993; 269: Lefebvre C, Manheimer E, Glanville J: Searching for studies. In: Cochrane Handbook for Systematic Reviews of Interventions, version Higgins JPT, Greene S (Eds). Available at: Accessed April 26, Higgins J, Altman D: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions, version Higgins JPT, Greene S (Eds). Available at: Accessed April 26, Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: Higgins J, Deeks J: Selecting studies and collecting data. In: Cochrane Handbook for Systematic Reviews of Interventions, version Higgins JPT, Greene S (Eds). Available at: Accessed April 26, Furukawa TA, Barbui C, Cipriani A, et al: Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 2006; 59: Deeks J, Higgins J, Altman D: Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions, version Higgins JPT, Greene S (Eds). Available at: cochrane-handbook.org. Accessed April 26, Afifi W, Abdallah I, Yosry M, et al: The effect of a single dose of 3% hypertonic saline versus mannitol 20% for treatment of brain oedema and intracranial hypertension in postoperative patients with supratentorial gliomata. Egyptian J Anaesthesia 2003; 19: Schatzmann C, Heissler HE, König K, et al: Treatment of elevated intracranial pressure by infusions of 10% saline in severely head injured patients. Acta Neurochir Suppl 1998; 71: Suarez JI, Qureshi AI, Bhardwaj A, et al: Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998; 26: Horn P, Münch E, Vajkoczy P, et al: Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res 1999; 21: Schwarz S, Georgiadis D, Aschoff A, et al: Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002; 33: Koenig MA, Bryan M, Lewin JL III, et al: Reversal of transtentorial herniation with hypertonic saline. Neurol 2008; 70: Oddo M, Levine JM, Frangos S, et al: Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry 2009; 80: Kerwin AJ, Schinco MA, Tepas JJ III, et al: The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: A pilot study. J Trauma 2009; 67: Ware ML, Nemani VM, Meeker M, et al: Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: A preliminary study. Neurosurg 2005; 57: Paczynski RP: Osmotherapy. Basic concepts and controversies. Crit Care Clin 1997; 13: Muizelaar JP, Lutz HA III, Becker DP: Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg 1984; 61: Burke AM, Quest DO, Chien S, et al: The effects of mannitol on blood viscosity. J Neurosurg 1981; 55: Mendelow AD, Teasdale GM, Russell T, et al: Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg 1985; 63: Donato T, Shapira Y, Artru A, et al: Effect of mannitol on cerebrospinal fluid dynamics and brain tissue edema. Anesth Analg 1994; 78: Crit Care Med 2011 Vol. 39, No. 3
6 41. Alvarez B, Ferrer-Sueta G, Radi R: Slowing of peroxynitrite decomposition in the presence of mannitol and ethanol. Free Radic Biol Med 1998; 24: Korenkov AI, Pahnke J, Frei K, et al: Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia. Neurosurg Rev 2000; 23: Cooper DJ, Myles PS, McDermott FT, et al: Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: A randomized controlled trial. JAMA 2004; 291: Murphy N, Auzinger G, Bernel W, et al: The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39: Rozet I, Tontisirin N, Muangman S, et al: Effect of equiosmolar solutions of mannitol versus hypertonic saline on intraoperative brain relaxation and electrolyte balance. Anesthesiology 2007; 107: Wu CT, Chen LC, Kuo CP, et al: A comparison of 3% hypertonic saline and mannitol for brain relaxation during elective supratentorial brain tumor surgery. Anesth Analg 110: Gemma M, Cozzi S, Tommasino C, et al: 7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol 1997; 9: Crit Care Med 2011 Vol. 39, No
Mannitol versus Hypertonic Saline for Management of Elevated Intracranial Pressure Jerry Altshuler, PharmD; Diana Esaian, PharmD, BCPS
Mannitol versus Hypertonic Saline for Management of Elevated Intracranial Pressure Jerry Altshuler, PharmD; Diana Esaian, PharmD, BCPS The intracranial compartment consists of predominantly brain parenchyma
More informationGunnar Bentsen, MD; Harald Breivik, MD, DMSc, FRCA; Tryggve Lundar, MD, DMSc; Audun Stubhaug, MD, DMSc
Continuing Medical Education Article Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with
More informationJMSCR Vol 04 Issue 08 Page August 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i8.12 Mannitol Vs Hypertonic Saline in the Treatment
More informationHypertonic Saline in the Treatment of Intracranial Hypertension
ISPUB.COM The Internet Journal of Advanced Nursing Practice Volume 11 Number 1 Hypertonic Saline in the Treatment of Intracranial Hypertension L Griffin Citation L Griffin. Hypertonic Saline in the Treatment
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal compartment syndrome, as complication of fluid resuscitation, 331 338 abdominal perfusion pressure, 332 fluid restriction practice
More informationIntracranial hypertension and cerebral edema are cardinal
High-Osmolarity Saline in Neurocritical Care: Systematic Review and Meta-Analysis* Christos Lazaridis, MD 1,,3 ; Ron Neyens, PharmD 1,4 ; Jeffrey Bodle, MD ; Stacia M. DeSantis, PhD 5 Background and Purpose:
More informationHypertonic saline (HTS) and mannitol are used to
A Comparison of 3% Hypertonic Saline and Mannitol for Brain Relaxation During Elective Supratentorial Brain Tumor Surgery Ching-Tang Wu, MD,* Liang-Chih Chen, MD, Chang-Po Kuo, MD,* Da-Tong Ju, MD, Cecil
More informationHypertonic Saline and Mannitol Therapy in Critical Care Neurology
Analytic Reviews Hypertonic Saline and Mannitol Therapy in Critical Care Neurology Journal of Intensive Care Medicine 28(1) 3-11 ª The Author(s) 2013 Reprints and permission: sagepub.com/journalspermissions.nav
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Closed reduction methods for acute anterior shoulder dislocation [Cochrane Protocol] Kanthan Theivendran, Raj Thakrar, Subodh Deshmukh,
More informationMedical Management of Intracranial Hypertension. Joao A. Gomes, MD FAHA Head, Neurointensive Care Unit Cerebrovascular Center
Medical Management of Intracranial Hypertension Joao A. Gomes, MD FAHA Head, Neurointensive Care Unit Cerebrovascular Center Anatomic and Physiologic Principles Intracranial compartments Brain 80% (1,400
More informationKlinikum Frankfurt Höchst
Blood pressure management in hemorrhagic stroke Blood pressure in acute ICH Do we need additional trials after INTERACT2 and ATTACH-II? Focus.de Department of Neurology,, Germany Department of Neurology,
More informationMannitol for Resuscitation in Acute Head Injury: Effects on Cerebral Perfusion and Osmolality
Original articles Mannitol for Resuscitation in Acute Head Injury: Effects on Cerebral Perfusion and Osmolality J. A. MYBURGH*, S. B. LEWIS *Intensive Care Unit, Royal Adelaide Hospital, Adelaide, SOUTH
More informationLinee guida sul trauma cranico: sempre attuali? Leonardo Bussolin AOU Meyer
Linee guida sul trauma cranico: sempre attuali? Leonardo Bussolin AOU Meyer Vavilala MS, et al Retrospective multicenter cohort study Prehospital Arena ED OR - ICU Each 1% increase in adherence was associated
More informationMedicines Protocol HYPERTONIC SALINE 5%
Medicines Protocol HYPERTONIC SALINE 5% HYPERTONIC SALINE 5% v1.0 1/4 Protocol Details Version 1.0 Legal category POM Staff grades Registered Paramedic Registered Nurse Specialist Paramedic (Critical Care)
More informationAny closer to evidence based practice? Asma Salloo Chris Hani Baragwantah Academic Hospital University of Witwatersrand
Any closer to evidence based practice? Asma Salloo Chris Hani Baragwantah Academic Hospital University of Witwatersrand Evidence Pathophysiology Why? Management Non-degenerative, Non-congenital insult
More informationAgomelatine versus placebo: A meta-analysis of published and unpublished trials
Agomelatine versus placebo: A meta-analysis of published and unpublished trials (Protocol for a systematic review, Ulm, January 17, 2011) Markus Kösters, Andrea Cipriani, Giuseppe Guaiana, Thomas Becker
More informationTraumatic Brain Injury:
Traumatic Brain Injury: Changes in Management Across the Spectrum of Age and Time Omaha 2018 Trauma Symposium June 15, 2018 Gail T. Tominaga, M.D., F.A.C.S. Scripps Memorial Hospital La Jolla Outline Background
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Percutaneous access for endovascular aortic aneurysm repair: a systematic review and meta-analysis Shahin Hajibandeh, Shahab Hajibandeh,
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationA protocol for a systematic review on the impact of unpublished studies and studies published in the gray literature in meta-analyses
Systematic Reviews This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. A protocol for a systematic
More informationSupplementary Online Content
Supplementary Online Content Tsai WC, Wu HY, Peng YS, et al. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic
More informationCochrane Pregnancy and Childbirth Group Methodological Guidelines
Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews
More informationLearning from Systematic Review and Meta analysis
Learning from Systematic Review and Meta analysis Efficacy and Safety of Antiscabietic Agents: A Systematic Review and Network Meta analysis of Randomized Controlled Trials KUNLAWAT THADANIPON, MD 4 TH
More informationSystematic Reviews and Meta- Analysis in Kidney Transplantation
Systematic Reviews and Meta- Analysis in Kidney Transplantation Greg Knoll MD MSc Associate Professor of Medicine Medical Director, Kidney Transplantation University of Ottawa and The Ottawa Hospital KRESCENT
More informationPRACTICE GUIDELINE. DEFINITIONS: Mild head injury: Glasgow Coma Scale* (GCS) score Moderate head injury: GCS 9-12 Severe head injury: GCS 3-8
PRACTICE GUIDELINE Effective Date: 9-1-2012 Manual Reference: Deaconess Trauma Services TITLE: TRAUMATIC BRAIN INJURY GUIDELINE OBJECTIVE: To provide practice management guidelines for traumatic brain
More informationCLINICAL INVESTIGATIONS. Materials and Methods
CLINICAL INVESTIGATIONS Anesthesiology 2007; 107:697 704 Copyright 2007, the American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Effect of Equiosmolar Solutions of Mannitol
More informationHow Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage
How Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage Rachael Scott, Pharm.D. PGY2 Critical Care Pharmacy Resident Pharmacy Grand Rounds August 21, 2018 2018 MFMER slide-1 Patient
More informationsurgery: A systematic review and meta-analysis protocol
Title Perioperative dexmedetomidine and outcomes after adult cardiac surgery: A systematic review and meta-analysis protocol Registration PROSPERO (registered December 8 th, 2015) Authors David McIlroy
More informationMannitol for acute traumatic brain injury (Review)
Wakai A, McCabe A, Roberts I, Schierhout G This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2013, Issue 8 http://www.thecochranelibrary.com
More informationThe management of ICH when to operate when not to?
The management of ICH when to operate when not to? Intracranial Hemorrhage High Incidence o Accounts for 10-15% of all strokes 1,2,5 o 80,000 cases in US; 2 million WW 2,5 o Incidence doubles for African-
More informationPerioperative Management of Traumatic Brain Injury. C. Werner
Perioperative Management of Traumatic Brain Injury C. Werner Perioperative Management of TBI Pathophysiology Monitoring Oxygenation CPP Fluid Management Glycemic Control Temperature Management Surgical
More information11 th Annual Cerebrovascular Symposium 5/11-12/2017. Hypertonic Use D E R E K C L A R K
Hypertonic Use D E R E K C L A R K 1 Outline Types of hyperosmolar therapy Review Cerebral Na Physiology Differences between periphery and BBB Acute phase Subacute phase Chronic changes Hypertonic Saline
More informationShobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland, Ohio
Shobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland, Ohio Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester,
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first
More informationAntifibrinolytic drugs for acute traumatic injury(review)
Cochrane Database of Systematic Reviews Antifibrinolytic drugs for acute traumatic injury(review) KerK,RobertsI,ShakurH,CoatsTJ KerK,RobertsI,ShakurH,CoatsTJ. Antifibrinolytic drugs for acute traumatic
More informationResults. NeuRA Worldwide incidence April 2016
Introduction The incidence of schizophrenia refers to how many new cases there are per population in a specified time period. It is different from prevalence, which refers to how many existing cases there
More informationTraumatic brain injury
Introduction It is well established that traumatic brain injury increases the risk for a wide range of neuropsychiatric disturbances, however there is little consensus on whether it is a risk factor for
More informationDownloaded from:
Arnup, SJ; Forbes, AB; Kahan, BC; Morgan, KE; McKenzie, JE (2016) The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality. Trials,
More informationDatabase of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York.
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling Brown
More informationTHE EFFICACY AND SAFETY OF CILOSTAZOL IN SUBARACHNOID HEMORRHAGE. A META- ANALYSIS OF RANDOMIZED AND NON RANDOMIZED STUDIES DR. MUHAMMAD F.
THE EFFICACY AND SAFETY OF CILOSTAZOL IN SUBARACHNOID HEMORRHAGE. A META- ANALYSIS OF RANDOMIZED AND NON RANDOMIZED STUDIES DR. MUHAMMAD F. ISHFAQ ZEENAT QURESHI STROKE INSTITUTE AND UNIVERSITY OF TENNESSEE,
More informationData extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing.
Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds Bradley M, Cullum N, Nelson E A, Petticrew M, Sheldon T, Torgerson D Authors' objectives
More informationRobert M. Jacobson, M.D. Department of Pediatric and Adolescent Medicine Mayo Clinic, Rochester, Minnesota
How to Conduct a Systematic Review: A Workshop 24 th Annual Primary Care Research Methods & Statistics Conference, San Antonio, Texas Saturday, December 3, 2011 Robert M. Jacobson, M.D. Department of Pediatric
More information"Small Volume" Resuscitation for Trauma Cases : PRO Aspects
"Small Volume" Resuscitation for Trauma Cases : PRO Aspects Jim Holliman, M.D., F.A.C.E.P. Program Manager, Afghanistan Health Care Sector Reconstruction Project Center for Disaster and Humanitarian Assistance
More informationTrials and Tribulations of Systematic Reviews and Meta-Analyses
Trials and Tribulations of Systematic Reviews and Meta-Analyses Mark A. Crowther and Deborah J. Cook St. Joseph s Hospital, Hamilton, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada Systematic
More informationAlectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis
Showa Univ J Med Sci 30 2, 309 315, June 2018 Original Alectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis Ryo MANABE 1, Koichi ANDO
More informationMeta Analysis. David R Urbach MD MSc Outcomes Research Course December 4, 2014
Meta Analysis David R Urbach MD MSc Outcomes Research Course December 4, 2014 Overview Definitions Identifying studies Appraising studies Quantitative synthesis Presentation of results Examining heterogeneity
More informationEvaluating the results of a Systematic Review/Meta- Analysis
Open Access Publication Evaluating the results of a Systematic Review/Meta- Analysis by Michael Turlik, DPM 1 The Foot and Ankle Online Journal 2 (7): 5 This is the second of two articles discussing the
More informationResults. NeuRA Hypnosis June 2016
Introduction may be experienced as an altered state of consciousness or as a state of relaxation. There is no agreed framework for administering hypnosis, but the procedure often involves induction (such
More informationChapter 8: Cerebral protection Stephen Lo
Chapter 8: Cerebral protection Stephen Lo Introduction There will be a variety of neurological pathologies that you will see within the intensive care. The purpose of this chapter is not to cover all neurological
More informationB I O L I F E R E S E A R C H A R T I C L E
AN INTERNATIONAL QUARTERLY JOURNAL OF BIOLOGY & LIFE SCIENCES 5(1):111-117 B I O L I F E R E S E A R C H A R T I C L E Comparative study between versus Hypertonic saline continuous infusion versus Hypertonic
More informationOptimum sodium levels in children with brain injury. Professor Sunit Singhi, Head, Department of Pediatrics, Head, Pediatric
India Optimum sodium levels in children with brain injury Professor Sunit Singhi, Head, Department of Pediatrics, Head, Pediatric Sodium and brain Sodium - the major extracellular cation and most important
More informationAntithrombotic management options for acute ischemic large-vessel stroke: A meta-analysis of randomized clinical trials
Antithrombotic management options for acute ischemic large-vessel stroke: A meta-analysis of randomized clinical trials Background Stroke affects one in every 20 individuals in developed countries and
More informationCerebral Blood Flow Thresholds for Cerebral Ischemia in. Traumatic Brain Injury. A Systematic Review.
Cerebral Blood Flow Thresholds for Cerebral Ischemia in Traumatic Brain Injury. A Systematic Review. Marco Botteri, MD, Elisabetta Bandera, MD, Cosetta Minelli, MD, PhD, Nicola Latronico, MD Neuroanesthesia
More informationAlbumina nel paziente critico. Savona 18 aprile 2007
Albumina nel paziente critico Savona 18 aprile 2007 What Is Unique About Critical Care RCTs patients eligibility is primarily defined by location of care in the ICU rather than by the presence of a specific
More informationThe Placebo Attributable Fraction in General Medicine: Protocol for a metaepidemiological
Fixed and uploaded on September 4, 2018 The Placebo Attributable Fraction in General Medicine: Protocol for a metaepidemiological Study of Cochrane Reviews Yusuke Tsutsumi1, 2, Yasushi Tsujimoto1, 3, Aran
More informationThe QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews
The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews David Moher 1, Alessandro Liberati 2, Douglas G Altman 3, Jennifer Tetzlaff 1 for the QUOROM Group
More informationUpdate on Guidelines for Traumatic Brain Injury
Update on Guidelines for Traumatic Brain Injury Current TBI Guidelines Shirley I. Stiver MD, PhD Department of Neurosurgery Guidelines for the management of traumatic brain injury Journal of Neurotrauma
More informationResults. NeuRA Treatments for internalised stigma December 2017
Introduction Internalised stigma occurs within an individual, such that a person s attitude may reinforce a negative self-perception of mental disorders, resulting in reduced sense of selfworth, anticipation
More informationBrain under pressure Managing ICP. Giuseppe
Brain under pressure Managing ICP Giuseppe Citerio giuseppe.citerio@unimib.it @Dr_Cit Intro Thresholds Treating HICP Conclusions NO COI for this presentation Produces pressure gradients: herniation HIGH
More informationFluid Treatments in Sepsis: Meta-Analyses
Fluid Treatments in Sepsis: Recent Trials and Meta-Analyses Lauralyn McIntyre MD, FRCP(C), MSc Scientist, Ottawa Hospital Research Institute Assistant Professor, University of Ottawa Department of Epidemiology
More informationBACKGROUND AND SCIENTIFIC RATIONALE. Protocol Code: ISRCTN V 1.0 date 30 Jan 2012
BACKGROUND AND SCIENTIFIC RATIONALE Protocol Code: ISRCTN15088122 V 1.0 date 30 Jan 2012 Traumatic Brain Injury 10 million killed or hospitalised every year 90% in low and middle income countries Mostly
More informationRaised Intracranial Pressure (ICP): Management in Emergency Department
Raised Intracranial Pressure (ICP): Management in Emergency Department Author: Dr. Shruti Sangani*, Dr. Samira Parikh** INTRODUCTION: Elevated intracranial pressure (ICP) is a potentially devastating complication
More informationMeta-analyses: analyses:
Meta-analyses: analyses: how do they help, and when can they not? Lee Hooper Senior Lecturer in research synthesis & nutrition l.hooper@uea.ac.uk 01603 591268 Aims Systematic Reviews Discuss the scientific
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Prophylactic cranial irradiation in patients with non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled
More informationCochrane Bone, Joint & Muscle Trauma Group How To Write A Protocol
A p r i l 2 0 0 8 Cochrane Bone, Joint & Muscle Trauma Group How To Write A Protocol This booklet was originally produced by the Cochrane Renal Group to make the whole process of preparing a protocol as
More informationPhysiology and Monitoring of Intravascular Volume Status in the Neurosurgical Patient
Physiology and Monitoring of Intravascular Volume Status in the Neurosurgical Patient David J. Stone MD I. Introduction and General Issues The focal point in the care of neurosurgical patients is the control
More informationProblem solving therapy
Introduction People with severe mental illnesses such as schizophrenia may show impairments in problem-solving ability. Remediation interventions such as problem solving skills training can help people
More informationSupplementary Online Content
Supplementary Online Content Wu HY, Peng YS, Chiang CK, et al. Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening
More informationA Study to Describe Cerebral Perfusion Pressure Optimization Practice among ICU Patients of Tertiary Hospital of South India
International Journal of Caring Sciences January-April 2018 Volume 11 Issue 1 Page 296 Original Article A Study to Describe Cerebral Perfusion Pressure Optimization Practice among ICU Patients of Tertiary
More informationTITLE: Optimal Oxygen Saturation Range for Adults Suffering from Traumatic Brain Injury: A Review of Patient Benefit, Harms, and Guidelines
TITLE: Optimal Oxygen Saturation Range for Adults Suffering from Traumatic Brain Injury: A Review of Patient Benefit, Harms, and Guidelines DATE: 11 April 2014 CONTEXT AND POLICY ISSUES Traumatic brain
More informationHypertonic Saline Versus Mannitol To Improve Brain Relaxation In Craniotomy: A Case Study
University of New England DUNE: DigitalUNE Nurse Anesthesia Capstones School of Nurse Anesthesia 6-2017 Hypertonic Saline Versus Mannitol To Improve Brain Relaxation In Craniotomy: A Case Study Morgan
More informationSurgical Neurology International
Surgical Neurology International OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA Review
More informationDefinition พ.ญ.ส ธ ดา เย นจ นทร. Epidemiology. Definition 5/25/2016. Seizures after stroke Can we predict? Poststroke seizure
Seizures after stroke Can we predict? พ.ญ.ส ธ ดา เย นจ นทร PMK Epilepsy Annual Meeting 2016 Definition Poststroke seizure : single or multiple convulsive episode(s) after stroke and thought to be related
More informationResuscitation fluids in critical care
Resuscitation fluids in critical care John A Myburgh MBBCh PhD FCICM UNSW Professor of Critical Care Medicine The George Institute for Global Health University of New South Wales St George Hospitals, Sydney
More informationPROTOCOL. Francesco Brigo, Luigi Giuseppe Bongiovanni
COMMON REFERENCE-BASED INDIRECT COMPARISON META-ANALYSIS OF INTRAVENOUS VALPROATE VERSUS INTRAVENOUS PHENOBARBITONE IN GENERALIZED CONVULSIVE STATUS EPILEPTICUS PROTOCOL Francesco Brigo, Luigi Giuseppe
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Drug-eluting balloon angioplasty versus non-stenting balloon angioplasty for peripheral arterial disease of the lower limbs [Cochrane Protocol]
More information2016 Top Papers in Critical Care
2016 Top Papers in Critical Care Briana Witherspoon DNP, APRN, ACNP-BC Assistant Director of Advanced Practice, Neuroscience Assistant in Division of Critical Care, Department of Anesthesiology Neuroscience
More informationCitation Characteristics of Research Published in Emergency Medicine Versus Other Scientific Journals
ORIGINAL CONTRIBUTION Citation Characteristics of Research Published in Emergency Medicine Versus Other Scientific From the Division of Emergency Medicine, University of California, San Francisco, CA *
More informationTherapeutic Hypothermia
Objectives Overview Therapeutic Hypothermia Nerissa U. Ko, MD, MAS UCSF Department of Neurology Critical Care Medicine and Trauma June 4, 2011 Hypothermia as a neuroprotectant Proven indications: Adult
More informationResults. NeuRA Forensic settings April 2016
Introduction Prevalence quantifies the proportion of individuals in a population who have a disease during a specific time period. Many studies have reported a high prevalence of various health problems,
More informationManagement of Traumatic Brain Injury. Olaide O. Ajayi, MD
Management of Traumatic Brain Injury Olaide O. Ajayi, MD Traumatic Brain Injury (TBI) A bump, blow or jolt to the head that disrupts the normal function of the brain 1 Mild: Brief change in mental status
More informationA meta-analysis of the effectiveness of hypertonic saline in treating Chinese mainland populations with high intracranial pressure.
Biomedical Research 2017; 28 (5): 2099-2105 ISSN 0970-938X www.biomedres.info A meta-analysis of the effectiveness of hypertonic saline in treating Chinese mainland populations with high intracranial pressure.
More informationACR OA Guideline Development Process Knee and Hip
ACR OA Guideline Development Process Knee and Hip 1. Literature searching frame work Literature searches were developed based on the scenarios. A comprehensive search strategy was used to guide the process
More informationCase 1. Case 5/30/2013. Traumatic Brain Injury : Review, Update, and Controversies
Case 1 Traumatic Brain Injury : Review, Update, and Controversies Shirley I. Stiver MD, PhD 32 year old male s/p high speed MVA Difficult extrication Intubated at scene Case BP 75 systolic / palp GCS 3
More informationIs the use of hypertonic saline effective in reducing intracranial pressure after traumatic brain injury?
Is the use of hypertonic saline effective in reducing intracranial pressure after traumatic brain injury? Clinical bottom line Hypertonic saline appears to be effective in reducing intracranial pressure
More informationInfluence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions
Saltaji et al. BMC Medical Research Methodology (218) 18:42 https://doi.org/1.1186/s12874-18-491- RESEARCH ARTICLE Open Access Influence of blinding on treatment effect size estimate in randomized controlled
More informationHyperosmolar Therapy for Raised Intracranial Pressure
T h e n e w e ngl a nd j o u r na l o f m e dic i n e clinical therapeutics Hyperosmolar Therapy for Raised Intracranial Pressure Allan H. Ropper, M.D. This Journal feature begins with a case vignette
More informationCholesterol lowering intervention for cardiovascular prevention in high risk patients with or without LDL cholesterol elevation
TrialResults-center.org www.trialresultscenter.org Cholesterol lowering intervention for cardiovascular prevention in high risk patients with or without LDL cholesterol elevation A systematic review and
More informationGLYCEMIC CONTROL IN NEUROCRITICAL CARE PATIENTS
GLYCEMIC CONTROL IN NEUROCRITICAL CARE PATIENTS David Zygun MD MSc FRCPC Professor and Director Division of Critical Care Medicine University of Alberta Zone Clinical Department Head Critical Care Medicine,
More informationManagement of Traumatic Brain Injury (and other neurosurgical emergencies)
Management of Traumatic Brain Injury (and other neurosurgical emergencies) Laurel Moore, M.D. University of Michigan 22 nd Annual Review February 7, 2019 Greetings from Michigan! Objectives for Today s
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Ray K K, Seshasai S R K, Wijesuriya S,
More information12/4/2017. Disclosure. Educational Objectives. Has been consultant for Bard, Chiesi
Temperature Management in Neuro ICU Kiwon Lee, MD, FACP, FAHA, FCCM Professor of Neurology, RWJ Medical School Chief of Neurology, RWJ University Hospital Director, RWJ Comprehensive Stroke Center Director,
More informationMaria B. ALBUJA-CRUZ, MD ALBUMIN: OVERRATED. Surgical Grand Rounds
Maria B. ALBUJA-CRUZ, MD ALBUMIN: OVERRATED Surgical Grand Rounds ALBUMIN Most abundant plasma protein 1/3 intravascular 50% of interstitial SKIN Synthesized in hepatocytes Transcapillary escape rate COP
More information7 TI - Epidemiology of intracerebral hemorrhage.
1 TI - Multiple postoperative intracerebral haematomas remote from the site of craniotomy. AU - Rapana A, et al. SO - Br J Neurosurg. 1998 Aug;1():-8. Review. IDS - PMID: 1000 UI: 991958 TI - Cerebral
More informationDeep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H
Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein
More informationMalignant Edema and Hemicraniectomy After Stroke
Malignant Edema and Hemicraniectomy After Stroke Sherri A. Braksick, MD March 29, 2017 No Financial Disclosures No Discussion of Off-Label Usage Objectives 1. Review the pathophysiology of edema after
More informationStandards for the reporting of new Cochrane Intervention Reviews
Methodological Expectations of Cochrane Intervention Reviews (MECIR) Standards for the reporting of new Cochrane Intervention Reviews 24 September 2012 Preface The standards below summarize proposed attributes
More informationResults. NeuRA Family relationships May 2017
Introduction Familial expressed emotion involving hostility, emotional over-involvement, and critical comments has been associated with increased psychotic relapse in people with schizophrenia, so these
More informationHow to do a meta-analysis. Orestis Efthimiou Dpt. Of Hygiene and Epidemiology, School of Medicine University of Ioannina, Greece
How to do a meta-analysis Orestis Efthimiou Dpt. Of Hygiene and Epidemiology, School of Medicine University of Ioannina, Greece 1 Overview (A brief reminder of ) What is a Randomized Controlled Trial (RCT)
More informationResults. NeuRA Mindfulness and acceptance therapies August 2018
Introduction involve intentional and non-judgmental focus of one's attention on emotions, thoughts and sensations that are occurring in the present moment. The aim is to open awareness to present experiences,
More information